This article identifies unique issues related to the tangential flow filtration of mammalian cell cultures, and presents an empirical approach to optimizing these processes.

This article identifies the technical, regulatory and business factors which limit a client's leverage in biopharmaceutical contract manufacturing relationships. The article proposes contractual structures to mitigate the impact of these factors and balance the client-contractor relationship.